TW201139430A - Aromatic compound containing nitrogen atom(s) - Google Patents

Aromatic compound containing nitrogen atom(s) Download PDF

Info

Publication number
TW201139430A
TW201139430A TW100110503A TW100110503A TW201139430A TW 201139430 A TW201139430 A TW 201139430A TW 100110503 A TW100110503 A TW 100110503A TW 100110503 A TW100110503 A TW 100110503A TW 201139430 A TW201139430 A TW 201139430A
Authority
TW
Taiwan
Prior art keywords
group
formula
oxy
methyl
compound
Prior art date
Application number
TW100110503A
Other languages
English (en)
Chinese (zh)
Inventor
Akihiro Furukawa
Hideki Kobayashi
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of TW201139430A publication Critical patent/TW201139430A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW100110503A 2010-03-29 2011-03-28 Aromatic compound containing nitrogen atom(s) TW201139430A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010074166 2010-03-29

Publications (1)

Publication Number Publication Date
TW201139430A true TW201139430A (en) 2011-11-16

Family

ID=44712167

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100110503A TW201139430A (en) 2010-03-29 2011-03-28 Aromatic compound containing nitrogen atom(s)

Country Status (2)

Country Link
TW (1) TW201139430A (ja)
WO (1) WO2011122458A1 (ja)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2322709T3 (es) * 2004-02-18 2009-06-25 Astrazeneca Ab Derivados de benzamida y su uso como agentes activadores de la glucocinasa.
WO2009083553A1 (en) * 2007-12-31 2009-07-09 Rheoscience A/S Azine compounds as glucokinase activators
PT2239253E (pt) * 2008-02-06 2013-09-17 Daiichi Sankyo Co Ltd Novo derivado de fenilpirrole
JP2011513253A (ja) * 2008-02-27 2011-04-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病を治療するためのカルボキサミド−ヘテロアリール誘導体

Also Published As

Publication number Publication date
WO2011122458A1 (ja) 2011-10-06

Similar Documents

Publication Publication Date Title
TWI432429B (zh) 新穎苯基吡咯衍生物
CA2511970C (en) Urea derivatives useful in the treatment of heart failure
JP5765753B2 (ja) トリアジン誘導体およびそれを含有する鎮痛作用を有する医薬組成物
US8901307B2 (en) Chemical compounds 251
TWI657076B (zh) 經取代磺醯胺化合物
CN112778276A (zh) 作为shp2抑制剂的化合物及其应用
JP2020500207A (ja) カルパインモジュレーター及びそれらの治療上の使用
TW201838966A (zh) 取代的二氫茚－４－甲醯胺及其類似物以及其使用方法
US20170001990A1 (en) Piperidine-dione derivatives
EA018988B1 (ru) Активаторы глюкокиназы
WO2020147739A1 (zh) 溶血磷脂酸受体拮抗剂及其制备方法
TW201524953A (zh) 治療活性化合物及其使用方法（二）
CN102256944A (zh) 鞘氨醇-1-磷酸受体拮抗剂
JP2023541612A (ja) Ｅｇｆｒ突然変異癌の抑制用化合物及びその医薬用途
CN108623576A (zh) 用于抑制激酶活性的吲唑类化合物及其组合物及应用
TW201326151A (zh) 具有ｐｇｄ２受體拮抗活性之雜環衍生物
CN102372697A (zh) 取代的嘧啶类化合物
WO2020103817A1 (zh) TGF-βR1抑制剂及其应用
CN115340528A (zh) 一种具有抗肿瘤活性的化合物及其用途
EP3083597B1 (en) Fluoromethyl-substituted pyrrole carboxamides as cav2.2 calcium channel blockers
CN111718332B (zh) 2-取代吡唑氨基-4-取代氨基-5-嘧啶甲酰胺类化合物、组合物及其应用
CN115605202A (zh) 具有血清素受体结合活性的芳香族杂环衍生物
CN114149409A (zh) 一种具有蛋白激酶抑制活性的（杂）芳基酰胺类化合物
TW201139430A (en) Aromatic compound containing nitrogen atom(s)
TW201206904A (en) Substituted pyridine compound